Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012, Article ID 476910, 9 pages
http://dx.doi.org/10.1155/2012/476910
Review Article

EGFR: A Master Piece in G1/S Phase Transition of Liver Regeneration

1Institut Cochin, Department of Endocrinology Metabolism and Cancer, Université Paris-Descartes, CNRS, UMR8104, 75014 Paris, France
2INSERM, U1016, 75014 Paris, France

Received 21 May 2012; Accepted 11 July 2012

Academic Editor: Anne Corlu

Copyright © 2012 Alexandra Collin de l'Hortet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Mead, L. Braun, D. A. Martin, and N. Fausto, “Induction of replicative competence (“priming”) in normal liver,” Cancer Research, vol. 50, no. 21, pp. 7023–7030, 1990. View at Google Scholar · View at Scopus
  2. E. M. Webber, P. J. Godowski, and N. Fausto, “In vivo response of hepatocytes to growth factors requires an initial priming stimulus,” Hepatology, vol. 19, no. 2, pp. 489–497, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. D. E. Cressman, L. E. Greenbaum, R. A. DeAngelis et al., “Liver failure and defective hepatocyte regeneration in interleukin-6- deficient mice,” Science, vol. 274, no. 5291, pp. 1379–1383, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Yamada, I. Kirillova, J. J. Peschon, and N. Fausto, “Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 4, pp. 1441–1446, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Ito, S. Kawata, S. Tamura et al., “Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes,” Biochemical and Biophysical Research Communications, vol. 198, no. 1, pp. 25–31, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. G. D. Block, J. Locker, W. C. Bowen et al., “Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF-α in a chemically defined (HGM) medium,” Journal of Cell Biology, vol. 132, no. 6, pp. 1133–1149, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Fausto, A. D. Laird, and E. M. Webber, “Role of growth factors and cytokines in hepatic regeneration,” The FASEB Journal, vol. 9, no. 15, pp. 1527–1536, 1995. View at Google Scholar · View at Scopus
  8. C. Berasain, E. R. García-Trevijano, J. Castillo et al., “Amphiregulin: an early trigger of liver regeneration in mice,” Gastroenterology, vol. 128, no. 2, pp. 424–432, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. G. K. Michalopoulos, “Liver regeneration: molecular mechanisms of growth control,” The FASEB Journal, vol. 4, no. 2, pp. 176–187, 1990. View at Google Scholar · View at Scopus
  10. N. Fausto, “Growth factors in liver development, regeneration and carcinogenesis,” Cytokine and Growth Factor Reviews, vol. 3, no. 3, pp. 219–234, 1991. View at Google Scholar · View at Scopus
  11. G. K. Michalopoulos, “Liver regeneration,” Journal of Cellular Physiology, vol. 213, no. 2, pp. 286–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. K. J. Riehle, Y. Y. Dan, J. S. Campbell, and N. Fausto, “New concepts in liver regeneration,” Journal of Gastroenterology and Hepatology, vol. 26, supplement 1, pp. 203–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Gilgenkrantz and A. Collin de l'Hortet, “New insights into liver regeneration,” Clinics and Research in Hepatology and Gastroenterology, vol. 35, no. 10, pp. 623–629, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Matsumoto and T. Nakamura, “Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions,” Critical Reviews in Oncogenesis, vol. 3, no. 1-2, pp. 27–54, 1992. View at Google Scholar · View at Scopus
  15. A. Bell, Q. Chen, M. C. DeFrances, G. K. Michalopoulos, and R. Zarnegar, “The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice,” Oncogene, vol. 18, no. 4, pp. 887–895, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Sakata, H. Takayama, R. Sharp, J. S. Rubin, G. Merlino, and W. J. LaRochelle, “Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers,” Cell Growth and Differentiation, vol. 7, no. 11, pp. 1513–1523, 1996. View at Google Scholar · View at Scopus
  17. G. Shiota and H. Kawasaki, “Hepatocyte growth factor in transgenic mice,” International Journal of Experimental Pathology, vol. 79, no. 5, pp. 267–277, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Borowiak, A. N. Garratt, T. Wüstefeld, M. Strehle, C. Trautwein, and C. Birchmeier, “Met provides essential signals for liver regeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10608–10613, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. V. M. Factor, D. Seo, T. Ishikawa et al., “Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice,” PLoS ONE, vol. 5, no. 9, Article ID e12739, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Paranjpe, W. C. Bowen, A. W. Bell, K. Nejak-Bowen, J. H. Luo, and G. K. Michalopoulos, “Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference,” Hepatology, vol. 45, no. 6, pp. 1471–1477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Mitchell, M. Nivison, L. F. Jackson et al., “Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration,” The Journal of Biological Chemistry, vol. 280, no. 4, pp. 2562–2568, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. W. Burgess, “EGFR family: structure physiology signalling and therapeutic target,” Growth Factors, vol. 26, no. 5, pp. 263–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. L. Schechter, D. F. Stern, and L. Vaidyanathan, “The neu oncogene: an erb-B-related gene encoding a 185,000-M(r) tumour antigen,” Nature, vol. 312, no. 5994, pp. 513–516, 1984. View at Google Scholar · View at Scopus
  24. D. J. Riese II and D. F. Stern, “Specificity within the EGF family/ErbB receptor family signaling network,” BioEssays, vol. 20, no. 1, pp. 41–48, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Cohen and G. A. Elliott, “The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse,” Journal of Investigative Dermatology, vol. 40, pp. 1–5, 1963. View at Google Scholar · View at Scopus
  26. A. B. Singh and R. C. Harris, “Autocrine, paracrine and juxtacrine signaling by EGFR ligands,” Cellular Signalling, vol. 17, no. 10, pp. 1183–1193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Yamauchi, K. Ueki, K. Tobe et al., “Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone,” Nature, vol. 390, no. 6655, pp. 91–96, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Yamauchi, K. Ueki, K. Tobe et al., “Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression,” Endocrine Journal, vol. 45, supplement, pp. S27–S31, 1998. View at Google Scholar · View at Scopus
  29. T. Ravid, C. Sweeney, P. Gee, K. L. Carraway, and T. Goldkorn, “Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation,” The Journal of Biological Chemistry, vol. 277, no. 34, pp. 31214–31219, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Filosto, E. M. Khan, E. Tognon et al., “EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization,” PLoS ONE, vol. 6, no. 8, Article ID e23240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. B. A. Gusterson and K. D. Hunter, “Should we be surprised at the paucity of response to EGFR inhibitors?” The Lancet Oncology, vol. 10, no. 5, pp. 522–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Y. Lin, K. Makino, W. Xia et al., “Nuclear localization of EGF receptor and its potential new role as a transcription factor,” Nature Cell Biology, vol. 3, no. 9, pp. 802–808, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. H. W. Lo, X. Cao, H. Zhu, and F. Ali-Osman, “Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes,” Molecular Cancer Research, vol. 8, no. 2, pp. 232–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Casado, N. A. Callejas, J. Rodrigo et al., “Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy,” The FASEB Journal, vol. 15, no. 11, pp. 2016–2018, 2001. View at Google Scholar · View at Scopus
  35. K. Roepstorff, L. Grøvdal, M. Grandal, M. Lerdrup, and B. van Deurs, “Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer,” Histochemistry and Cell Biology, vol. 129, no. 5, pp. 563–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Sorkin and L. K. Goh, “Endocytosis and intracellular trafficking of ErbBs,” Experimental Cell Research, vol. 314, no. 17, pp. 3093–3106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Roepstorff, M. V. Grandal, L. Henriksen et al., “Differential effects of EGFR ligands on endocytic sorting of the receptor,” Traffic, vol. 10, no. 8, pp. 1115–1127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Levkowitz, H. Waterman, E. Zamir et al., “c-Cb1/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor,” Genes and Development, vol. 12, no. 23, pp. 3663–3674, 1998. View at Google Scholar · View at Scopus
  39. S. J. Decker, “Epidermal growth factor and transforming growth factor-alpha induce differential processing of the epidermal growth factor receptor,” Biochemical and Biophysical Research Communications, vol. 166, no. 2, pp. 615–621, 1990. View at Publisher · View at Google Scholar · View at Scopus
  40. R. S. Carver, M. C. Stevenson, L. A. Scheving, and W. E. Russell, “Diverse expression of ErbB receptor proteins during rat liver development and regeneration,” Gastroenterology, vol. 123, no. 6, pp. 2017–2027, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. D. W. Threadgill, A. A. Dlugosz, L. A. Hansen et al., “Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype,” Science, vol. 269, no. 5221, pp. 230–234, 1995. View at Google Scholar · View at Scopus
  42. A. Natarajan, B. Wagner, and M. Sibilia, “The EGF receptor is required for efficient liver regeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17081–17086, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. K. J. Wilson, C. Mill, S. Lambert et al., “EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling,” Growth Factors, vol. 30, no. 2, pp. 107–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Yarden and M. X. Sliwkowski, “Untangling the ErbB signalling network,” Nature Reviews Molecular Cell Biology, vol. 2, no. 2, pp. 127–137, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Fausto, J. S. Campbell, and K. J. Riehle, “Liver regeneration,” Hepatology, vol. 43, no. 2, pp. S45–S53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Wells, “EGF receptor,” International Journal of Biochemistry and Cell Biology, vol. 31, no. 6, pp. 637–643, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. Krall, E. M. Beyer, and G. MacBeath, “High- and low-affinity epidermal growth factor receptor-ligand interactions activate distinct signaling pathways,” PLoS ONE, vol. 6, no. 1, Article ID e15945, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Carpenter and S. Cohen, “Epidermal growth factor,” The Journal of Biological Chemistry, vol. 265, no. 14, pp. 7709–7712, 1990. View at Google Scholar · View at Scopus
  49. A. Ullrich and J. Schlessinger, “Signal transduction by receptors with tyrosine kinase activity,” Cell, vol. 61, no. 2, pp. 203–212, 1990. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Schlessinger, “Cell signaling by receptor tyrosine kinases,” Cell, vol. 103, no. 2, pp. 211–225, 2000. View at Google Scholar · View at Scopus
  51. G. A. Rodrigues, M. Falasca, Z. Zhang, S. H. Ong, and J. Schlessinger, “A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling,” Molecular and Cellular Biology, vol. 20, no. 4, pp. 1448–1459, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Shao, H. Y. Cheng, R. G. Cook, and D. J. Tweardy, “Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor,” Cancer Research, vol. 63, no. 14, pp. 3923–3930, 2003. View at Google Scholar · View at Scopus
  53. T. K. Guren, J. Ødegård, H. Abrahamsen et al., “EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes,” Journal of Cellular Physiology, vol. 196, no. 1, pp. 113–123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. K. M. Quesnelle, A. L. Boehm, and J. R. Grandis, “STAT-mediated EGFR signaling in cancer,” Journal of Cellular Biochemistry, vol. 102, no. 2, pp. 311–319, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Rotin, A. M. Honegger, B. L. Margolis, A. Ullrich, and J. Schlessinger, “Presence of SH2 domains of phospholipase Cγ1 enhances substrate phosphorylation by increasing the affinity toward the epidermal growth factor receptor,” The Journal of Biological Chemistry, vol. 267, no. 14, pp. 9678–9683, 1992. View at Google Scholar · View at Scopus
  56. G. Carpenter and Q. S. Ji, “Phospholipase C-γ as a signal-transducing element,” Experimental Cell Research, vol. 253, no. 1, pp. 15–24, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Kiso, S. Kawata, S. Tamura et al., “Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy,” Hepatology, vol. 22, no. 5, pp. 1584–1590, 1995. View at Google Scholar · View at Scopus
  58. D. B. Stolz, W. M. Mars, B. E. Petersen, T. H. Kim, and G. K. Michalopoulos, “Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat,” Cancer Research, vol. 59, no. 16, pp. 3954–3960, 1999. View at Google Scholar · View at Scopus
  59. S. Kiso, S. Kawata, S. Tamura et al., “Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy,” Gastroenterology, vol. 124, no. 3, pp. 701–707, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Lambotte, A. Saliez, S. Triest et al., “Effect of sialoadenectomy and epidermal growth factor administration on liver regeneration after partial hepatectomy,” Hepatology, vol. 25, no. 3, pp. 607–612, 1997. View at Publisher · View at Google Scholar · View at Scopus
  61. D. E. Jones, R. Tran-Patterson, D. M. Cui, D. Davin, K. P. Estell, and D. M. Miller, “Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration,” American Journal of Physiology, vol. 268, no. 5, pp. G872–G878, 1995. View at Google Scholar · View at Scopus
  62. S. Noguchi, Y. Ohba, and T. Oka, “Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice,” Journal of Endocrinology, vol. 128, no. 3, pp. 425–431, 1991. View at Google Scholar · View at Scopus
  63. W. E. Russell, W. K. Kaufmann, S. Sitaric, N. C. Luetteke, and D. C. Lee, “Liver regeneration and hepatocarcinogenesis in transforming growth factor-α-targeted mice,” Molecular Carcinogenesis, vol. 15, no. 3, pp. 183–189, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Draghi, U. Armato, P. G. Andreis, and L. Mengato, “The stimulation by epidermal growth factor (urogastrone) of the growth of neonatal rat hepatocytes in primary tissue culture and its modulation by serum and associated pancreatic hormones,” Journal of Cellular Physiology, vol. 103, no. 1, pp. 129–147, 1980. View at Google Scholar · View at Scopus
  65. C. De Juan, M. Benito, A. Alvarez, and I. Fabregat, “Differential proliferative response of cultured fetal and regenerating hepatocytes to growth factors and hormones,” Experimental Cell Research, vol. 202, no. 2, pp. 495–500, 1992. View at Publisher · View at Google Scholar · View at Scopus
  66. J. A. McGowan, A. J. Strain, and N. L. R. Bucher, “DNA synthesis in primary cultures of adult rat hepatocytes in a defined medium: effects of epidermal growth factor, insulin, glucagon, and cyclic-AMP,” Journal of Cellular Physiology, vol. 108, no. 3, pp. 353–363, 1981. View at Google Scholar · View at Scopus
  67. S. Paranjpe, W. C. Bowen, G. C. Tseng, J. H. Luo, A. Orr, and G. K. Michalopoulos, “RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats,” American Journal of Pathology, vol. 176, no. 6, pp. 2669–2681, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. L. A. Scheving, L. Zhang, M. C. Stevenson, S. K. Eun, and W. E. Russell, “The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling,” American Journal of Physiology, vol. 291, no. 1, pp. G16–G25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. L. A. Scheving, M. C. Stevenson, X. Zhang, and W. E. Russell, “Cultured rat hepatocytes upregulate Akt and ERK in an ErbB-2-dependent manner,” American Journal of Physiology, vol. 295, no. 2, pp. G322–G331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Loyer, S. Cariou, D. Glaise, M. Bilodeau, G. Baffet, and C. Guguen-Guillouzo, “Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro: evidence of a mitogen restriction point in mid-late G1,” The Journal of Biological Chemistry, vol. 271, no. 19, pp. 11484–11492, 1996. View at Google Scholar · View at Scopus
  71. D. G. Rickheim, C. J. Nelsen, J. T. Fassett, N. A. Timchenko, L. K. Hansen, and J. H. Albrecht, “Differential regulation of cyclins D1 and D3 in hepatocyte proliferation,” Hepatology, vol. 36, no. 1, pp. 30–38, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Talarmin, C. Rescan, S. Cariou et al., “The mitogen-activated protein kinase kinase/extracellular signal- regulated kinase cascade activation is a key signalling pathway involved in the regulation of G1 phase progression in proliferating hepatocytes,” Molecular and Cellular Biology, vol. 19, no. 9, pp. 6003–6011, 1999. View at Google Scholar · View at Scopus
  73. Y. Luo, C. J. Dixon, J. F. Hall, P. J. White, and M. R. Boarder, “A role for Akt in epidermal growth factor-stimulated cell cycle progression in cultured hepatocytes: generation of a hyperproliferative window after adenoviral expression of constitutively active Akt,” Journal of Pharmacology and Experimental Therapeutics, vol. 321, no. 3, pp. 884–891, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. D. C. Guttridge, C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, “NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1,” Molecular and Cellular Biology, vol. 19, no. 8, pp. 5785–5799, 1999. View at Google Scholar · View at Scopus
  75. M. Hinz, D. Krappmann, A. Eichten, A. Heder, C. Scheidereit, and M. Strauss, “NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition,” Molecular and Cellular Biology, vol. 19, no. 4, pp. 2690–2698, 1999. View at Google Scholar · View at Scopus
  76. E. Albi, G. Rossi, N. M. Maraldi et al., “Involvement of nuclear phosphatidylinositol-dependent phospholipases C in cell cycle progression during rat liver regeneration,” Journal of Cellular Physiology, vol. 197, no. 2, pp. 181–188, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. B. H. Zhang and G. C. Farrell, “Chronic ethanol consumption disrupts complexation between EGF receptor and phospholipase C-γ1: relevance to impaired hepatocyte proliferation,” Biochemical and Biophysical Research Communications, vol. 257, no. 1, pp. 89–94, 1999. View at Publisher · View at Google Scholar · View at Scopus
  78. T. K. Guren, H. Abrahamsen, G. H. Thoresen, E. Babaie, T. Berg, and T. Christoffersen, “EGF-induced activation of Stat1, Stat3, and Stat5b is unrelated to the stimulation of DNA synthesis in cultured hepatocytes,” Biochemical and Biophysical Research Communications, vol. 258, no. 3, pp. 565–571, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Zhang, J. Y. Ji, M. Yu et al., “YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway,” Nature Cell Biology, vol. 11, no. 12, pp. 1444–1450, 2009. View at Google Scholar · View at Scopus
  80. C. Wang, L. Zhang, Q. He et al., “Differences in Yes-associated protein and mRNA levels in regenerating liver and hepatocellular carcinoma,” Molecular Medicine Reports, vol. 5, no. 2, pp. 410–414, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. K. P. Lee, J. H. Lee, T. S. Kim et al., “The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 18, pp. 8248–8253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Lu, Y. Li, S. M. Kim et al., “Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 4, pp. 1437–1442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Song, K. K. Mak, L. Topol et al., “Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 4, pp. 1431–1436, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. M. P. Sanderson, P. J. Dempsey, and A. J. Dunbar, “Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors,” Growth Factors, vol. 24, no. 2, pp. 121–136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. U. Sahin, G. Weskamp, K. Kelly et al., “Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands,” Journal of Cell Biology, vol. 164, no. 5, pp. 769–779, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. D. C. Lee, S. W. Sunnarborg, C. L. Hinkle et al., “TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase,” Annals of the New York Academy of Sciences, vol. 995, pp. 22–38, 2003. View at Google Scholar · View at Scopus
  87. C. L. Hinkle, S. W. Sunnarborg, D. Loiselle et al., “Selective roles for tumor necrosis factor α-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family. The juxtamembrane stalk determines cleavage efficiency,” The Journal of Biological Chemistry, vol. 279, no. 23, pp. 24179–24188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. G. M. Argast, J. S. Campbell, J. T. Brooling, and N. Fausto, “Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication,” The Journal of Biological Chemistry, vol. 279, no. 33, pp. 34530–34536, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. X. M. Lin, Y. B. Liu, F. Zhou, Y. L. Wu, L. Chen, and H. Q. Fang, “Expression of tumor necrosis factor-alpha converting enzyme in liver regeneration after partial hepatectomy,” World Journal of Gastroenterology, vol. 14, no. 9, pp. 1353–1357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Ekberg, M. Luther, T. Nakamura, and J. O. Jansson, “Growth hormone promotes early initiation of hepatocyte growth factor gene expression in the liver of hypophysectomized rats after partial hepatectomy,” Journal of Endocrinology, vol. 135, no. 1, pp. 59–67, 1992. View at Google Scholar · View at Scopus
  91. P. A. Pennisi, J. J. Kopchick, S. Thorgeirsson, D. Leroith, and S. Yakar, “Role of Growth Hormone (GH) in liver regeneration,” Endocrinology, vol. 145, no. 10, pp. 4748–4755, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Zerrad-Saadi, M. Lambert-Blot, C. Mitchell et al., “GH receptor plays a major role in liver regeneration through the control of EGFR and ERK1/2 activation,” Endocrinology, vol. 152, no. 7, pp. 2731–2741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. L. Blaas, J. W. Kornfeld, D. Schramek et al., “Disruption of the growth hormone-signal transducer and activator of transcription 5-insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis,” Hepatology, vol. 51, no. 4, pp. 1319–1326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. C. Desbois-Mouthon, D. Wendum, A. Cadoret et al., “Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout,” The FASEB Journal, vol. 20, no. 6, pp. 773–775, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. R. Reinehr and D. Häussinger, “CD95 death receptor and epidermal growth factor receptor (EGFR) in liver cell apoptosis and regeneration,” Archives of Biochemistry and Biophysics, vol. 518, no. 1, pp. 2–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. C. Torre, S. Benhamouche, C. Mitchell et al., “The transforming growth factor-α and cyclin D1 genes are direct targets of β-catenin signaling in hepatocyte proliferation,” Journal of Hepatology, vol. 55, no. 1, pp. 86–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Sekine, P. J. A. Gutiérrez, B. Y. A. Lan, S. Feng, and M. Hebrok, “Liver-specific loss of β-catenin results in delayed hepatocyte proliferation after partial hepatectomy,” Hepatology, vol. 45, no. 2, pp. 361–368, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. X. Tan, U. Apte, A. Micsenyi et al., “Epidermal growth factor receptor: a novel target of the Wnt/β-catenin pathway in liver,” Gastroenterology, vol. 129, no. 1, pp. 285–302, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. X. Tan, J. Behari, B. Cieply, G. K. Michalopoulos, and S. P. S. Monga, “Conditional deletion of beta-catenin reveals its role in liver growth and regeneration,” Gastroenterology, vol. 131, no. 5, pp. 1561–1572, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. J. C. Bucuvalas, J. A. Horn, and S. D. Chernausek, “Resistance to growth hormone in children with chronic liver disease,” Pediatric Transplantation, vol. 1, no. 1, pp. 73–79, 1997. View at Google Scholar · View at Scopus
  101. N. Assy, Y. Pruzansky, D. Gaitini, Z. Shen Orr, Z. Hochberg, and Y. Baruch, “Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction,” Journal of Hepatology, vol. 49, no. 1, pp. 34–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. T. Ichikawa, K. Nakao, K. Hamasaki et al., “Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease,” Hepatology International, vol. 1, pp. 287–294, 2007. View at Google Scholar
  103. M. Scacchi, A. I. Pincelli, and F. Cavagnini, “Growth hormone in obesity,” International Journal of Obesity, vol. 23, no. 3, pp. 260–271, 1999. View at Google Scholar · View at Scopus
  104. C. L. Arteaga, “Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia,” Seminars in Oncology, vol. 29, no. 5, pp. 3–9, 2002. View at Google Scholar · View at Scopus
  105. C. Berasain, J. Castillo, J. Prieto, and M. A. Avila, “New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system,” Liver International, vol. 27, no. 2, pp. 174–185, 2007. View at Publisher · View at Google Scholar · View at Scopus